A roadmap should change. Markets shift. Competitors move. Customers surprise you. New information comes in that deserves to alter the plan. That is part of the work. The problem is roadmap whiplash. Roadmap whiplash is what happens when product decisions keep changing direction without a clear enough reason. A priority becomes urgent, then negotiable, then urgent again. A feature moves up because one stakeholder is worried, then moves back because another stakeholder is loude

Corporate decision-makers have a familiar reflex when risk starts to feel uncomfortable. Get more data. Run a bigger survey. Broaden the sample. Add more respondents. Make the findings more projectible. Cast the net wider so no one can say the team missed something important. Sometimes that instinct is right. If you are sizing a market, measuring awareness, estimating consideration, forecasting adoption, or comparing segments, quantitative research can do its job well. It hel

Most B2B research is designed to feel safe. It prioritizes representativeness. It seeks consensus. It works hard to make sure every segment is covered, every voice counted, every finding defensible in a room full of skeptics. Those goals make sense if the primary risk you’re managing is organizational discomfort. They make far less sense if you’re trying to decide what to build, what to cut, or where to place a meaningful bet. Representativeness is a statistical virtue, not a